502 related articles for article (PubMed ID: 15347726)
41. Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorate: option for subsequent care after the use of liquid 188Re in a balloon catheter.
Kotzerke J; Fenchel S; Guhlmann A; Stabin M; Rentschler M; Knapp FF; Reske SN
Nucl Med Commun; 1998 Aug; 19(8):795-801. PubMed ID: 9751935
[TBL] [Abstract][Full Text] [Related]
42. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy.
Nakamoto Y; Saga T; Misaki T; Kobayashi H; Sato N; Ishimori T; Kosugi S; Sakahara H; Konishi J
J Nucl Med; 2000 Nov; 41(11):1898-904. PubMed ID: 11079502
[TBL] [Abstract][Full Text] [Related]
43. Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model.
Lee YJ; Chung JK; Kang JH; Jeong JM; Lee DS; Lee MC
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):235-41. PubMed ID: 19727716
[TBL] [Abstract][Full Text] [Related]
44. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
[TBL] [Abstract][Full Text] [Related]
45. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
Knoop K; Schwenk N; Schmohl K; Müller A; Zach C; Cyran C; Carlsen J; Böning G; Bartenstein P; Göke B; Wagner E; Nelson PJ; Spitzweg C
J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085
[TBL] [Abstract][Full Text] [Related]
46. Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression.
Willhauck MJ; Sharif Samani BR; Gildehaus FJ; Wolf I; Senekowitsch-Schmidtke R; Stark HJ; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2007 Nov; 92(11):4451-8. PubMed ID: 17698909
[TBL] [Abstract][Full Text] [Related]
47. Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma.
Mu D; Huang R; Li S; Ma X; Lou C; Kuang A
Cancer Gene Ther; 2012 Jun; 19(6):402-11. PubMed ID: 22498723
[TBL] [Abstract][Full Text] [Related]
48. Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.
Chai W; Yin X; Ren L; Cai M; Long T; Zhou M; Tang Y; Yang N; Hu S
Clin Transl Oncol; 2015 Oct; 17(10):795-802. PubMed ID: 26115738
[TBL] [Abstract][Full Text] [Related]
49. Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter.
Huang R; Zhao Z; Ma X; Li S; Gong R; Kuang A
Cancer Gene Ther; 2011 Feb; 18(2):144-52. PubMed ID: 21037556
[TBL] [Abstract][Full Text] [Related]
50. Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell-Mediated Sodium Iodide Symporter (
Schug C; Kitzberger C; Sievert W; Spellerberg R; Tutter M; Schmohl KA; Eberlein B; Biedermann T; Steiger K; Zach C; Schwaiger M; Multhoff G; Wagner E; Nelson PJ; Spitzweg C
Clin Cancer Res; 2019 Oct; 25(19):5997-6008. PubMed ID: 31196853
[TBL] [Abstract][Full Text] [Related]
51. Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.
Klutz K; Willhauck MJ; Dohmen C; Wunderlich N; Knoop K; Zach C; Senekowitsch-Schmidtke R; Gildehaus FJ; Ziegler S; Fürst S; Göke B; Wagner E; Ogris M; Spitzweg C
Hum Gene Ther; 2011 Dec; 22(12):1563-74. PubMed ID: 21851208
[TBL] [Abstract][Full Text] [Related]
52. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
53. Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk.
Shin JH; Chung JK; Kang JH; Lee YJ; Kim KI; Kim CW; Jeong JM; Lee DS; Lee MC
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):425-32. PubMed ID: 14689242
[TBL] [Abstract][Full Text] [Related]
54. Potential usefulness of baculovirus-mediated sodium-iodide symporter reporter gene as non-invasively gene therapy monitoring in liver cancer cells: an in vitro evaluation.
Pan Y; Wu H; Liu S; Zhou X; Yin H; Li B; Zhang Y
Technol Cancer Res Treat; 2014 Apr; 13(2):139-48. PubMed ID: 23919394
[TBL] [Abstract][Full Text] [Related]
55. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells.
Haberkorn U; Henze M; Altmann A; Jiang S; Morr I; Mahmut M; Peschke P; Kübler W; Debus J; Eisenhut M
J Nucl Med; 2001 Feb; 42(2):317-25. PubMed ID: 11216532
[TBL] [Abstract][Full Text] [Related]
56. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.
Grünwald GK; Vetter A; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Wagner E; Göke B; Holm PS; Ogris M; Spitzweg C
J Nucl Med; 2013 Aug; 54(8):1450-7. PubMed ID: 23843567
[TBL] [Abstract][Full Text] [Related]
57. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
[TBL] [Abstract][Full Text] [Related]
58. Treatment with rhenium-188-perrhenate and iodine-131 of NIS-expressing mammary cancer in a mouse model remarkably inhibited tumor growth.
Dadachova E; Nguyen A; Lin EY; Gnatovskiy L; Lu P; Pollard JW
Nucl Med Biol; 2005 Oct; 32(7):695-700. PubMed ID: 16243644
[TBL] [Abstract][Full Text] [Related]
59. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
60. Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells.
Tan J; Li W; Wang P
Chin J Cancer; 2011 Aug; 30(8):574-80. PubMed ID: 21801606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
